Lorus Therapeutics' Virulizin shows better antitumor activity than Taxol in preclinical studies Jan. 10, 2001
Oxford BioMedica initiates phase I/II clinical trial of TroVax as treatment of colorectal cancer Jan. 8, 2001
Cell Genesys reports further promising results from phase I trial of GVAX pancreatic cancer vaccine Jan. 3, 2001
Pierre Fabre describes bacterial cell wall protein with potential as cancer immunotherapy Dec. 21, 2000
RSS